Propylthiouracil Market

A thiourea antithyroid agent. Propythiouracil inhibits the synthesis of thyroxine and inhibits the peripheral conversion of throxine to tri-iodothyronine. It is used in the treatment of hyperthyroidism.

Propylthiouracil Market contains market size and forecasts of Propylthiouracil (PTU) in global, including the following market information:

Global Propylthiouracil (PTU) Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Propylthiouracil (PTU) Market Sales, 2017-2022, 2023-2028, (M Pcs)

Global top five Propylthiouracil (PTU) companies in 2021 (%)

The global Propylthiouracil (PTU) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Finished Drug Product Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Propylthiouracil (PTU) include Actavis (TEVA ), Par Pharmaceutical (Endo International), Apotex Corporation, Cardinal Health, Pharmascience (Joddes), Hikma, Dr. Herbrand KG, Shanghai Pharmaceuticals and Shanghai Zhaohui Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Propylthiouracil (PTU) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Propylthiouracil (PTU) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (M Pcs)

Global Propylthiouracil (PTU) Market Segment Percentages, by Type, 2021 (%)

Finished Drug Product

Active Pharmaceutical Ingredients

Global Propylthiouracil (PTU) Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (M Pcs)

Global Propylthiouracil (PTU) Market Segment Percentages, by Application, 2021 (%)

Radioiodine Therapy

Hyperthyroidism Operation

Thyroid Medication

Other

Global Propylthiouracil (PTU) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (M Pcs)

Global Propylthiouracil (PTU) Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Propylthiouracil (PTU) revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Propylthiouracil (PTU) revenues share in global market, 2021 (%)

Key companies Propylthiouracil (PTU) sales in global market, 2017-2022 (Estimated), (M Pcs)

Key companies Propylthiouracil (PTU) sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Actavis (TEVA )

Par Pharmaceutical (Endo International)

Apotex Corporation

Cardinal Health

Pharmascience (Joddes)

Hikma

Dr. Herbrand KG

Shanghai Pharmaceuticals

Shanghai Zhaohui Pharmaceutical

Guangdong South China Pharmaceutical Group

Guangzhou Kanghe Pharmaceutical

Jinghua Pharmaceutical Group

Suzhou Dongrui Pharmaceutical